[go: up one dir, main page]

NO940276L - Triglyceridpreparater - Google Patents

Triglyceridpreparater

Info

Publication number
NO940276L
NO940276L NO940276A NO940276A NO940276L NO 940276 L NO940276 L NO 940276L NO 940276 A NO940276 A NO 940276A NO 940276 A NO940276 A NO 940276A NO 940276 L NO940276 L NO 940276L
Authority
NO
Norway
Prior art keywords
acid
triglyceride
preparation
naturally derived
compounds
Prior art date
Application number
NO940276A
Other languages
English (en)
Norwegian (no)
Other versions
NO940276D0 (no
Inventor
David Frederick Horrobin
Austin Mcmordie
Mehar Singh Manku
Philip Knowles
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939301582A external-priority patent/GB9301582D0/en
Priority claimed from GB939301801A external-priority patent/GB9301801D0/en
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of NO940276D0 publication Critical patent/NO940276D0/no
Publication of NO940276L publication Critical patent/NO940276L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Cosmetics (AREA)
NO940276A 1993-01-27 1994-01-26 Triglyceridpreparater NO940276L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939301582A GB9301582D0 (en) 1993-01-27 1993-01-27 Triglycerides
GB939301801A GB9301801D0 (en) 1993-01-29 1993-01-29 Triglycerides

Publications (2)

Publication Number Publication Date
NO940276D0 NO940276D0 (no) 1994-01-26
NO940276L true NO940276L (no) 1994-07-28

Family

ID=26302346

Family Applications (2)

Application Number Title Priority Date Filing Date
NO940277A NO940277L (no) 1993-01-27 1994-01-26 Triglycerider og blandinger av slike
NO940276A NO940276L (no) 1993-01-27 1994-01-26 Triglyceridpreparater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO940277A NO940277L (no) 1993-01-27 1994-01-26 Triglycerider og blandinger av slike

Country Status (11)

Country Link
US (2) US5670540A (fr)
EP (2) EP0609001A3 (fr)
JP (2) JPH07126160A (fr)
KR (2) KR940018343A (fr)
CN (2) CN1104497A (fr)
AU (2) AU683027B2 (fr)
CA (2) CA2114421A1 (fr)
MY (1) MY112705A (fr)
NO (2) NO940277L (fr)
NZ (2) NZ250728A (fr)
SG (2) SG49810A1 (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9423625D0 (en) * 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
ATE201961T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
EP0739590B1 (fr) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycérides, riches en acides gras polyinsaturés
EP0739591B1 (fr) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycérides riches en acides gras polyinsaturés
EP0739589B1 (fr) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycérides, riches en acides gras polyinsaturés
ATE201962T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
ES2225879T3 (es) * 1995-05-01 2005-03-16 Scarista Limited Esteres de acido nicotinico y composiciones farmaceuticas que los contienen.
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
WO1997021434A1 (fr) * 1995-12-11 1997-06-19 Inholtra, Inc. Regime alimentaire a base de complements nutritionnels permettant de soulager les symptomes de l'arthrite
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9606216D0 (en) * 1996-03-25 1996-05-29 Scotia Holdings Plc Polyethylene glycol esters of fatty acids
AU731785B2 (en) * 1996-03-28 2001-04-05 Gist-Brocades B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
ES2203806T3 (es) * 1996-06-03 2004-04-16 Croda International Plc Compuestos y usos de los mismos.
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
JP4062639B2 (ja) * 1996-12-23 2008-03-19 日本水産株式会社 皮膚外用剤
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
JP2001525364A (ja) * 1997-12-12 2001-12-11 パーデュー・リサーチ・ファンデーション 糖尿病を治療する方法及び組成物
US6013665A (en) * 1997-12-16 2000-01-11 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6136795A (en) * 1998-11-18 2000-10-24 Omni Nutraceuticals, Inc Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9901808D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Drugs for treatment of psychiatric and brain disorders
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
WO2001078531A2 (fr) * 2000-04-18 2001-10-25 Natural As Poudre d'acide linoleique conjugue
WO2002069964A1 (fr) 2001-03-05 2002-09-12 Ernest Stephen P Formulation enterale
JP2003048831A (ja) * 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
JP4791662B2 (ja) * 2001-09-30 2011-10-12 大和ハウス工業株式会社 断熱基礎を採用する建物における床下収納構造
US6652774B2 (en) * 2001-12-20 2003-11-25 Ferro Corporation Glycerin triester plasticizer
KR101435707B1 (ko) 2002-06-19 2014-09-01 디에스엠 아이피 어셋츠 비.브이. 미생물 세포와 미생물 오일용 파스퇴르살균 방법
PT1542670E (pt) * 2002-09-24 2013-07-11 Suntory Holdings Ltd Composição com efeitos na prevenção do declínio, melhoramento ou aumento de respostas normais de aptidões cognitivas de uma pessoa saudável
US7041840B2 (en) * 2002-12-18 2006-05-09 Alberta Research Council Inc. Antioxidant triacylglycerols and lipid compositions
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
JP2006524187A (ja) * 2003-01-31 2006-10-26 ザ プロクター アンド ギャンブル カンパニー 哺乳類のケラチン組織の外観を改善する手段
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
CA2436650A1 (fr) * 2003-08-06 2005-02-06 Naturia Inc. Compositions d'acides linoleniques conjugues : synthese, purification et utilisations
JP4522075B2 (ja) * 2003-10-29 2010-08-11 サントリーホールディングス株式会社 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
JP2006083136A (ja) * 2004-09-17 2006-03-30 Suntory Ltd ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
GB0425658D0 (en) * 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
KR100693150B1 (ko) 2005-04-06 2007-03-13 주식회사 리포젠 재구성된 트리글리세라이드 지질을 포함하는 식품 보충물조성물
JP5697293B2 (ja) * 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
JP5967855B2 (ja) * 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
AU2007257523B2 (en) 2006-06-08 2013-04-11 Mars, Incorporated Use of at least one polyphenol for promoting eye health
US8003813B2 (en) * 2006-06-27 2011-08-23 Pos Pilot Plant Corporation Process for separating saturated and unsaturated fatty acids
KR101430214B1 (ko) 2006-12-28 2014-08-18 산토리 홀딩스 가부시키가이샤 신경 재생제
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20100010088A1 (en) * 2007-11-01 2010-01-14 Wake Forest University School Of Medicine Compositions and Methods for Prevention and Treatment of Mammalian Diseases
JP5428107B2 (ja) * 2007-11-27 2014-02-26 出光興産株式会社 扁平上皮癌細胞増殖抑制剤
WO2009099886A1 (fr) * 2008-01-31 2009-08-13 Monsanto Technology Llc Procédé d’amélioration de dépôt de déhydroépiandrostérone (dha) et fonction et/ou développement associés
US8202526B2 (en) * 2008-02-21 2012-06-19 Semperit Aktiengesellschaft Holding Prophylactic article
FR2940281B1 (fr) * 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
US20110217370A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen
JPWO2012153832A1 (ja) 2011-05-12 2014-07-31 日本水産株式会社 炎症性疾患用皮膚外用組成物
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
EP3546446A1 (fr) 2013-11-15 2019-10-02 DS Biopharma Limited Sels pharmaceutiquement acceptables d'acides gras polyinsaturés hydroxy
EP3101138B1 (fr) 2013-12-04 2021-05-05 Nippon Suisan Kaisha, Ltd. Huile microbienne, procédé pour produire une huile microbienne, huile microbienne concentrée et procédé pour produire une huile microbienne concentrée
WO2015185698A1 (fr) 2014-06-04 2015-12-10 Dignity Sciences Limited Compositions pharmaceutiques comprenant dgla et utilisation de celles-ci
CN113896628A (zh) 2015-05-13 2022-01-07 Ds生物制药有限公司 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法
WO2017013492A1 (fr) 2015-07-21 2017-01-26 Dignity Sciences Limited Compositions comprenant du 15-hepe destinées à être utilisées dans le traitement ou la prévention du cancer et d'une maladie neurologique
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
WO2025038940A1 (fr) * 2023-08-16 2025-02-20 Savor Foods Limited Système et procédé de fabrication de triglycérides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
JPS60222419A (ja) * 1984-04-17 1985-11-07 Terumo Corp 脂肪輸液剤
US4847296A (en) * 1984-09-13 1989-07-11 Babayan Vigen K Triglyceride preparations for the prevention of catabolism
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
US5151291A (en) * 1985-12-27 1992-09-29 Nisshin Flour Milling Co., Ltd. Glycerides of eicosapentaenoic acid, processes for preparing the same and oil and fat products containing the same
US5246726A (en) * 1986-03-21 1993-09-21 Efamol Ltd. Iron-containing composition and method for treatment of cancer
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention
JPS6416564A (en) * 1987-07-10 1989-01-20 Chisso Corp Composition for food additive
JPH0216988A (ja) * 1988-07-04 1990-01-19 Idemitsu Petrochem Co Ltd 濃縮された長鎖高度不飽和脂肪酸グリセリドの製造方法
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
WO1994010125A1 (fr) * 1992-10-27 1994-05-11 Sandoz Ltd. Derives de la glycerine et leur utilisation

Also Published As

Publication number Publication date
EP0609001A3 (fr) 1994-11-02
AU5382094A (en) 1994-08-04
NZ250727A (en) 1996-01-26
SG49810A1 (en) 1998-06-15
CN1105016A (zh) 1995-07-12
US5866703A (en) 1999-02-02
AU683027B2 (en) 1997-10-30
NO940277L (no) 1994-07-28
JPH07179398A (ja) 1995-07-18
MY112705A (en) 2001-08-30
EP0611569A2 (fr) 1994-08-24
KR940018090A (ko) 1994-08-16
SG49190A1 (en) 1998-05-18
AU673700B2 (en) 1996-11-21
AU5382194A (en) 1994-08-04
CN1104497A (zh) 1995-07-05
KR940018343A (ko) 1994-08-16
EP0611569A3 (fr) 1997-07-30
CA2114422A1 (fr) 1994-07-28
NO940277D0 (no) 1994-01-26
NZ250728A (en) 1996-01-26
NO940276D0 (no) 1994-01-26
CA2114421A1 (fr) 1994-07-28
EP0609001A2 (fr) 1994-08-03
US5670540A (en) 1997-09-23
JPH07126160A (ja) 1995-05-16

Similar Documents

Publication Publication Date Title
NO940276L (no) Triglyceridpreparater
NZ508578A (en) Fatty acid esters of phytosterol or phytostanol containing compositions useful in food products
AU2876289A (en) Salad/cooking oil balanced for health benefits
AU558168B2 (en) Fat containing diglycerides
CA2175842A1 (fr) Produits transesterifies a base d'huile de mais
ES8600689A1 (es) Procedimiento de preparar emulsiones.
MY106817A (en) Fat and oil composition
DK0673201T3 (da) Shortening-erstatning med reduceret fedtindhold til bageriprodukter
ES8502334A1 (es) "un procedimiento para preparar una composicion que contiene elastasa".
EP1135991A3 (fr) Composition d'huile et son utilisation
KR880007069A (ko) 트리글리세라이드 조성물
CA2166421A1 (fr) Composition aromatisante
KR0140401B1 (en) Anti-bloom triglyceride compositions
CA2405819A1 (fr) Poudre d'acide linoleique conjugue
JPS6413020A (en) Diclofenac sodium-containing emulsion external preparation
JPS5747446A (en) Nutrious food composition
ES456803A1 (es) Perfeccionamientos introducidos en una envoltura alimenticiatubular de colageno.
ATE427659T1 (de) Festphasenglyzerolyse
GB1225979A (fr)
JPS56164750A (en) Antifoaming agent for food
JPS5664772A (en) Storage of food
JPS54105081A (en) Method of raising marine fishes using fat yeasts
RU94002318A (ru) Триглицериды
MY103967A (en) Salad/cooking oil balanced for health benefits
JPS6439940A (en) Food or bevarage composition having modified flavor display